Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS)

DSpace Repository

Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS)

Show full item record

Files for download

Facebook

Simple item record

Publication Article, peer reviewed scientific
Title Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS)
Author(s) Bengtsson, Mariette ; Hammar, Oskar ; Mandl, Thomas ; Ohlsson, Bodil
Date 2011
English abstract
Abstract Background: Irritable bowel syndrome (IBS) and gastrointestinal (GI) dysmotility disorders have a similar clinical picture, although dysmotility disorders require the attention of a specialist. Patients with primary Sjögren’s syndrome (pSS) have also been described to suffer from IBS-like symptoms. No objective marker is available to distinguish between the patients. A visual analogue scale has been developed for IBS patients (VAS-IBS) to measure treatment response of GI symptoms and well-being in patients with IBS. The aim of the present study was to examine if VAS-IBS could be used to compare the degree of GI complaints in different patient populations, to get an objective marker to differentiate between the patients. Methods: The VAS-IBS consists of 7 VAS scales, namely, abdominal pain, diarrhoea, constipation, bloating and flatulence, vomiting and nausea, psychological well-being and the intestinal symptoms’ influence on daily life. Consecutive female patients suffering from IBS, dysmotility disorders and pSS were asked to complete the VAS-IBS questionnaire when visiting the out-patient clinics. In addition, a control population consisting of healthy female volunteers was included. Results: Healthy volunteers had almost no GI symptoms, whereas all 3 patient groups expressed symptoms. There was no statistical significant difference between IBS and dysmotility in any of the scales besides vomiting and nausea (p = 0.044). Except for constipation, patients with pSS had less severe symptoms than the others. Conclusion: The VAS-IBS questionnaire could be used to assess the level of GI symptoms. However, VAS scores do not help the clinicians to differentiate between IBS and other dysmotility disturbances.
DOI http://dx.doi.org/10.1186/1471-230X-11-122 (link to publisher's fulltext)
Publisher BioMedCentral
Host/Issue BMC Gastroenterology;11
Volume 122
ISSN 1471-230X
Pages 1-7
Language eng (iso)
Subject(s) health aspects
Irritable Bowel Syndrome
VAS-IBS
Medicine
Research Subject Categories::MEDICINE
Handle http://hdl.handle.net/2043/13049 (link to this page)

This item appears in the following Collection(s)

Show full item record

Search


Browse

My Account

Statistics